Social Affairs

[Photo] The 31st Busan International Film Festival (BIFF) is already bustling with crowds even before the opening

Bang In-Kwon
2026-10-06 12:14:07
[Edaily Reporter Bang In-kwon] On the 6th, the opening day of the 31st Busan International Film Festival (BIFF), visitors lined up to purchase merchandise at the Busan Cinema Center in Haeundae-gu, Busan. Now in its 31st year, the Busan International Film Festival will screen a total of 315 films—including 246 officially invited titles from 59 countries—at 31 screens across eight theaters, including the Busan Cinema Center, through the 15th.

[Edaily Reporter Bang In-kwon] On the 6th, the opening day of the 31st Busan International Film Festival (BIFF), visitors to the Busan Cinema Center in Haeundae-gu, Busan, are lining up to purchase merchandise.
Now in its 31st year, the Busan International Film Festival will screen a total of 315 films—including 246 officially invited titles from 59 countries—on 31 screens at eight theaters, including the Busan Cinema Center, through the 15th.

Economy

Corporation

IT·Science

Economy

Samsung Electro-Mechanics Secures Additional MLCC Orders Worth 285.6 Billion Won… Supply Contracts Estimated at About 4 Trillion Won This Year (Comprehensive)

Samsung Electro-Mechanics has signed a 285.6 billion won supply contract for multilayer ceramic capacitors (MLCCs) with a major global corporation. As demand for high-performance MLCCs is rapidly incr…
2026-10-06 12:08:48

Corporation

From promotional material production to contract review… Companies are cutting outsourcing contracts and hiring 'AI-trained employees'

#Public relations agency A has recently been requiring its employees to take training in “vibe coding” (a method in which a person describes the required functions in natural language, and generative …
2026-10-06 14:32:10

IT·Science

MedPacto, Inc. Receives Approval for Phase 1 Clinical Trial of ‘MP2021’ in Australia… “Secures Second Clinical Pipeline”

MedPacto, Inc. Research Institute (Photo: MedPacto, Inc.) MedPacto, Inc.(235980)announced on the 6th that it has received approval for the Phase 1 clinical trial plan (IND) for “MP2021,” a drug ca…
2026-10-06 14:51:02